Ad5/3-Cox2L-D24
AXP000069.1 · Oncolytic virus
- Platform
- adenovirus (Ad5/3 chimera, Cox-2 promoter, Delta-24)
- Originator
- University of Helsinki (Akseli Hemminki)
Names
| Name | Type | Source |
|---|---|---|
| Ad5/3-Cox2L-D24 | preferred name, code | curator, paper |
Virus
- Role
- Oncolytic
- Family
- Adenoviridae
- Virus
- human adenovirus 5 (NCBI Taxonomy 28285)
- Strain
- Ad5/3 chimera
- Replication
- conditionally replicating
- Modifications
- long cyclooxygenase-2 promoter drives E1A; Delta-24; Ad3 fiber knob
- Route
- intratumoral, intraperitoneal, intrapleural, intravenous
- Source
- evidence
Approvals
No regulatory approval recorded.
Clinical trials (0)
No trial in the latest ClinicalTrials.gov snapshot names this program.
Recent changes
No changes recorded in its trials yet.
Clinical papers
No confirmed clinical papers yet.
Other papers
Preclinical studies, reviews and other papers that name it.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 20237509 | Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumors. | Gene therapy | 2010 | name in title: Ad5/3-Cox2L-D24 |
| PMID 18632604 | Tissue-specific promoters active in CD44+CD24-/low breast cancer cells. | Cancer research | 2008 | name in abstract: Ad5/3-Cox2L-D24 |
Notes
ATAP construct (2007-2012); unarmed, replication controlled by a long cyclooxygenase-2 promoter.
How to cite
Ad5/3-Cox2L-D24 (AXP000069.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000069.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.